BridgeMD
New treatment option for Bladder Cancer
Official title Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study
ClinicalTrials.gov ID: NCT07339761
What this study is testing
- What it's testing
- Despite increasing recognition of sexual dysfunction and sexual distress as important survivorship issues in oncology, research and clinical attention remain uneven across cancer types. This imbalance is particularly evident in bladder cancer, where sexual health has received limited research and clinical attention.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- study 1a:
- The participant has one of the following diagnoses and received initial treatment approximately 12 months ago:
- Non-muscle-invasive bladder cancer treated with transurethral resection of the bladder (TUR-B)
- Non-muscle-invasive bladder cancer treated with TUR-B and subsequent intravesical instillation therapy with chemotherapy or immunotherapy
- Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder)
You likely can't join if
- study 1a:
- The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer...
- The participant has a history of breast cancer Inclusion Criteria study 1b:
- The participant is diagnosed with Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder)
- The participant speaks and understands Danish
- The participant is aged 18 years or older
See the full eligibility criteria
- study 1a:
- The participant has one of the following diagnoses and received initial treatment approximately 12 months ago:
- Non-muscle-invasive bladder cancer treated with transurethral resection of the bladder (TUR-B)
- Non-muscle-invasive bladder cancer treated with TUR-B and subsequent intravesical instillation therapy with chemotherapy or immunotherapy
- Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder)
- The participant has experienced changes and/or difficulties in sexual function related to the cancer diagnosis and/or its treatment
- The participant speaks and understands Danish
- The participant is aged 18 years or older
- The participant has read and understood the oral and written study information
- The participant has provided written informed consent
- study 1a:
- The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer, ovarian cancer, prostate cancer, or penile cancer
- The participant has a history of breast cancer Inclusion Criteria study 1b:
- The participant is diagnosed with Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder)
- The participant speaks and understands Danish
- The participant is aged 18 years or older
- The participant has read and understood the oral and written study information
- The participant has provided written informed consent Exclusion Criteria study 1b:
- The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer, ovarian cancer, prostate cancer, or penile cancer
- The participant has a history of breast cancer
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.